# Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024
> **Notice** · Notice with request for comments. · Published 2023-11-02 · 88 FR 75312
## Document
- **Document number:** 2023-24282
- **Category:** quota
- **Type:** Notice
- **Action:** Notice with request for comments.
- **Citation:** 88 FR 75312
- **Publication date:** 2023-11-02
## Abstract

The Drug Enforcement Administration (DEA) proposes to establish the 2024 aggregate production quotas (APQ) for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. For the 2024 quota year, DEA intends to allocate procurement quotas to DEA-registered manufacturers of schedule II controlled substances on a quarterly basis. In order to address domestic drug shortages of controlled substances, procurement quota allocations will be divided between quantities authorized for domestic sales and quantities authorized for export sales.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2023/11/02/2023-24282/proposed-aggregate-production-quotas-for-schedule-i-and-ii-controlled-substances-and-assessment-of)
---
*AI Analytics · CC0 1.0*